Action Direxion Daily Healthcar...

Direxion Daily Healthcare Bull 3X ETF (CURE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

116,5235

( 9,55% )

Prix Achat

Prix Vente

Volume échangé

147 507

107,72 Fourchette du Jour 116,35

66,00 Plage de 52 semaines 123,80

Clôture Veille

106,37

Ouverture

107,72

Dernière Transaction

115.61

Dernière heure de transaction

Volume moyen (3 m)

77 893

Volume financier

US$ 16 894 316

VWAP

114,5323

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Amsterdam, The Netherlands, and Holzgerlingen, Germany, July 01, 2020, 08:30 am CEST - Curetis N.V. in liquidatie (the "Company") today announced...

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, 08:00 am CET - Curetis N.V. in liquidatie (the "Company") today announced...

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Amsterdam, the Netherlands, Holzgerlingen, Germany April 20, 2020, 8:00 am CEST - Curetis N.V. in liquidatie (the "Company") announces that the...

Curetis and OpGen Close Business Combination

- Following approval of shareholders, companies sign German transfer agreement - Curetis GmbH and its subsidiaries Curetis USA Inc. and Ares...

OpGen Announces Shareholder Approval for Business Combination with Curetis

Vote approving transaction passes with 95% support for the transaction Closing expected in the coming days...

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transactionTransaction close anticipated...

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Shareholder proxy vote achieves quorum with 99% support for the transaction Final step in OpGen / Curetis...

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

GAITHERSBURG, Md., March 19, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision...

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

, a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for...

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 16:15 pm CET - Curetis N.V. (the "Company" and...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	22.0735	23.3705664373	94.45	116.66	94.18	89693	101.06948555	SP
4	19.3635	19.9294977357	97.16	116.66	86.9	93999	98.92272102	SP
12	25.3135	27.752987611	91.21	116.66	82.41	77893	93.78784956	SP
26	3.0335	2.67292272447	113.49	123.8	82.41	63887	100.88489479	SP
52	38.6935	49.7154053707	77.83	123.8	66	107148	89.50219994	SP
156	18.2335	18.5507172652	98.29	143.51	66	67781	94.87504879	SP
260	11.8535	11.3246393427	104.67	149.575	66	71345	102.43449606	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Direxion Daily Healthcare Bull 3X ETF (CURE)

Direxion Daily Healthcare Bull 3X ETF (CURE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CURE Dernières nouvelles

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Curetis and OpGen Close Business Combination

OpGen Announces Shareholder Approval for Business Combination with Curetis

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Direxion Daily Healthcare Bull 3X ETF (CURE)

Direxion Daily Healthcare Bull 3X ETF (CURE) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

CURE Dernières nouvelles

Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report

Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day

Curetis and OpGen Close Business Combination

OpGen Announces Shareholder Approval for Business Combination with Curetis

Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update

OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités